This document is a publication notice from the European Patent Office (EPO) for patent application EP4529928A2, filed by Translate Bio, Inc. The patent application, titled 'Compositions, Methods and Uses of Messenger RNA,' is scheduled for publication on March 18, 2026. It includes classifications related to therapeutic compositions, cancer treatments, and drug delivery systems.

As this is a patent publication, it does not impose new regulatory obligations or compliance deadlines on regulated entities. However, it is relevant for pharmaceutical and biotechnology companies involved in mRNA research and development, particularly concerning intellectual property and competitive landscapes in cancer therapeutics.